Publications by authors named "Fengxia Shi"

Claim this Profile
R
Rupture of a Giant Hepatic Artery Pseudoaneurysm into the Biliary Tract.
Feng-Xia Shi, Xian-Zheng Tan

Eur J Vasc Endovasc Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of progressive ossifying myositis caused by gene mutation].
Si-Qin Xie, Xiao-Fang Ding, Bing Zhang, Feng-Xia Shi, Li-Li Zhong

Zhongguo Dang Dai Er Ke Za Zhi· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Ping Li, Yang Liu, Yun Liang, Jian Bo, Sujun Gao, Fengxia Shi

Cancer Biol Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiments and simulations of surface cleaning for a gas-liquid two-phase jet.
Feng-Xia Shi, Jian Zhao, Yi Zhou, Huan Zhang

Water Sci Technol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal design of blade in pump as turbine based on multidisciplinary feasible method.
Miao Sen-Chun, Zhang Hong-Biao, Wang Ting-Ting, Wang Xiao-Hui, Shi Feng-Xia

Sci Prog· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of plastic mulching on soil CO efflux in a cotton field in northwestern China.
Zhimin Zhao, Fengxia Shi, Fachun Guan

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of twisted blade of pump as turbine based on high dimensional surrogate model.
Bingxiao Jiang, Junhu Yang, Xiaohui Wang, Fengxia Shi, Xiaobang Bai

Sci Prog· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy.
Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong

J Hematol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy.
Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong

J Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy.
Chunmeng Wang, Yang Liu, Liang Dong, Xiang Li, Qingming Yang, Fengxia Shi

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma.
Yang Liu, Chunmeng Wang, Xiang Li, Liang Dong, Qingming Yang, Fengxia Shi

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report.
Wen-Ying Zhang, Yao Wang, Ye-Lei Guo, Han-Ren Dai, Qing-Ming Yang, Feng-Xia Shi

Signal Transduct Target Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial.
Yang Liu, Yelei Guo, Zhiqiang Wu, Kaichao Feng, Chuan Tong, Fengxia Shi

Cytotherapy· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Chaochao Tan, Ying Huang, Fengxia Shi, Kui Tan, Qionghui Ma

J Med Virol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2019 Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features.
Fengxia Shi, Quanbo Yu, Wei Huang, Chaochao Tan

Korean J Radiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Systemic Inflammatory Response Syndrome Duration Predicts Infected Pancreatic Necrosis.
Chaochao Tan, Li Yang, Fengxia Shi, Jiliang Hu, Xingwen Zhang, Ting Shi

J Gastrointest Surg· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impeller meridional plane optimization of pump as turbine.
Miao Sen-Chun, Shi Zhi-Xiao, Wang Xiao-Hui, Shi Feng-Xia, Shi Guang-Tai

Sci Prog· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immature granulocytes: A novel biomarker of acute respiratory distress syndrome in patients with acute pancreatitis.
Ying Huang, Jie Xiao, Tao Cai, Li Yang, Fengxia Shi, Ting Shi

J Crit Care· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of CD3CD56 cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells.
Hanren Dai, Yong Zhou, Chuan Tong, Yelei Guo, Fengxia Shi

Cytotherapy· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.
Yajing Zhang, Wenying Zhang, Hanren Dai, Yao Wang, Fengxia Shi

Sci China Life Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia.
Hanren Dai, Wenying Zhang, Xiaolei Li, Qingwang Han, Yelei Guo, Fengxia Shi

Oncoimmunology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers.
Yajing Zhang, Lei Xia, Yan Zhang, Yao Wang, Xuechun Lu, Fengxia Shi

Expert Opin Biol Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Hui Fan, Xuechun Lu, Xiaohui Wang, Yang Liu, Bo Guo, Fengxia Shi

J Immunol Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis